# First Advantage Corp: overview

FA · Nasdaq · CIK 1210677 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fa.md) · [Financials](/companies/fa/financials.md) · [Filings](/companies/fa/filings.md) · [Insiders](/companies/fa/insiders.md)

Latest reported revenue: [$448.8m](/filings/0001193125-26-338063.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-338063).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [199](/filings/0001193125-25-269602.md) | [307 d](/filings/0001193125-26-076740.md) | [355](/filings/0001193125-26-211985.md) | [391](/filings/0001193125-26-338063.md) | [409](/filings/0001193125-25-269602.md) | [420 d](/filings/0001193125-26-076740.md) | [385](/filings/0001193125-26-211985.md) | [449](/filings/0001193125-26-338063.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [4.6%](/filings/0001193125-25-269602.md) | [(26.3%) d](/filings/0001193125-26-076740.md) | [2.1%](/filings/0001193125-26-211985.md) | [9.7%](/filings/0001193125-26-338063.md) | [10.3%](/filings/0001193125-25-269602.md) | [10.7% d](/filings/0001193125-26-076740.md) | [8.7%](/filings/0001193125-26-211985.md) | [12.7%](/filings/0001193125-26-338063.md) |
| Net margin | % | [(4.4%)](/filings/0001193125-25-269602.md) | [(32.7%) d](/filings/0001193125-26-076740.md) | [(11.6%)](/filings/0001193125-26-338063.md) | [0.1%](/filings/0001193125-26-338063.md) | [0.6%](/filings/0001193125-25-269602.md) | [0.8% d](/filings/0001193125-26-076740.md) | [0.6%](/filings/0001193125-26-338063.md) | [3.8%](/filings/0001193125-26-338063.md) |
| Diluted EPS | $ per share | [(0.06)](/filings/0001193125-25-269602.md) | not reported | [(0.24)](/filings/0001193125-26-211985.md) | [0.00](/filings/0001193125-26-338063.md) | [0.01](/filings/0001193125-25-269602.md) | not reported | [0.01](/filings/0001193125-26-211985.md) | [0.10](/filings/0001193125-26-338063.md) |
| Free cash flow | $m | [43.1 d](/filings/0001193125-25-269602.md) | [(86.0) d](/filings/0001193125-26-076740.md) | [19.0](/filings/0001193125-26-211985.md) | [36.1 d](/filings/0001193125-26-338063.md) | [71.2 d](/filings/0001193125-25-269602.md) | [62.2 d](/filings/0001193125-26-076740.md) | [46.6](/filings/0001193125-26-211985.md) | [68.9 d](/filings/0001193125-26-338063.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [712](/filings/0000950170-24-023094.md) | [810](/filings/0000950170-25-029067.md) | [764](/filings/0001193125-26-076740.md) | [860](/filings/0001193125-26-076740.md) | [1,574](/filings/0001193125-26-076740.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [9.0%](/filings/0000950170-24-023094.md) | [11.6%](/filings/0000950170-25-029067.md) | [10.7%](/filings/0001193125-26-076740.md) | [(7.3%)](/filings/0001193125-26-076740.md) | [8.4%](/filings/0001193125-26-076740.md) |
| Net margin | % | [2.3%](/filings/0000950170-24-023094.md) | [8.0%](/filings/0000950170-25-029067.md) | [4.9%](/filings/0001193125-26-076740.md) | [(12.8%)](/filings/0001193125-26-076740.md) | [(2.2%)](/filings/0001193125-26-076740.md) |
| Diluted EPS | $ per share | [0.11](/filings/0000950170-24-023094.md) | [0.43](/filings/0000950170-25-029067.md) | [0.26](/filings/0001193125-26-076740.md) | [(0.74)](/filings/0001193125-26-076740.md) | [(0.20)](/filings/0001193125-26-076740.md) |
| Free cash flow | $m | [141](/filings/0000950170-24-023094.md) | [207](/filings/0000950170-25-029067.md) | [161](/filings/0001193125-26-076740.md) | [26.5](/filings/0001193125-26-076740.md) | [188](/filings/0001193125-26-076740.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fa/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Silver Lake Group, L.L.C.](/funds/1418226.md) | 2026-06-30 | $1.62bn | 89,557,840 |  | Unchanged |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $217.7m | 12,063,590 |  | Added +6,073,445 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $193.0m | 10,690,358 |  | Added +291,644 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $138.1m | 7,652,905 |  | Reduced −1,424,776 |
| [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $89.6m | 7,620,910 |  | Reduced −287,480 |
| [CAT ROCK CAPITAL MANAGEMENT LP](/funds/1654648.md) | 2026-06-30 | $76.3m | 4,228,018 |  | Unchanged |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $74.3m | 4,118,357 |  | Added +593,576 |
| [BAMCO INC /NY/](/funds/1017918.md) | 2026-06-30 | $63.2m | 3,502,140 |  | Reduced −248,033 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $62.3m | 3,451,299 |  | Added +4,379 |
| [Boston Partners](/funds/1386060.md) | 2026-06-30 | $59.5m | 3,230,897 |  | Added +533,196 |

## Recent filings

[All 486 filings](/companies/fa/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-12 | 21:07 ET | [8-K](/filings/0001193125-26-347130.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-347130 |
| 2026-08-06 | 20:16 ET | [10-Q](/filings/0001193125-26-338063.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338063 |
| 2026-08-06 | 10:00 ET | [8-K](/filings/0001193125-26-336358.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-336358 |
| 2026-06-08 | 20:15 ET | [8-K](/filings/0001193125-26-261766.md) | 5.07 Shareholder vote results | 0001193125-26-261766 |
| 2026-05-07 | 20:17 ET | [10-Q](/filings/0001193125-26-211985.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211985 |
| 2026-05-07 | 10:01 ET | [8-K](/filings/0001193125-26-210077.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210077 |
| 2026-04-24 | 20:15 ET | [DEF 14A](/filings/0001193125-26-177294.md) | Proxy statement, period 2026-06-05 | 0001193125-26-177294 |
| 2026-02-26 | 21:16 ET | [10-K](/filings/0001193125-26-076740.md) | Annual report, period 2025-12-31 | 0001193125-26-076740 |
| 2026-02-26 | 11:00 ET | [8-K](/filings/0001193125-26-073071.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-073071 |
| 2026-01-30 | 21:15 ET | [8-K](/filings/0001193125-26-031830.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-031830 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-076740.md), filed Feb 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/ea6fce35-3eee-4ac7-91fe-75417a47578b)

## About the filer

- CIK: 1210677
- Tickers: FA
- Exchange: Nasdaq
- SIC code: 7374 Services-Computer Processing & Data Preparation
- State of incorporation: not reported
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.